Hotchkis & Wiley Capital Management LLC Acquires 19,613 Shares of Humana Inc. $HUM

Key Points

• Hotchkis & Wiley Capital Management LLC increased its position in Humana Inc. by 1.6%, owning over 1.23 million shares valued at approximately $327 million, making it their 28th biggest position.
• Humana reported a missed EPS for the quarter at $6.27, falling short of analyst expectations by $0.05, despite a revenue increase to $32.39 billion.
• The company has declared a quarterly dividend of $0.885, with a yield of 1.2%, set to be paid out at the end of October.

Hotchkis & Wiley Capital Management LLC grew its position in Humana Inc. (NYSE:HUM - Free Report) by 1.6% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 1,236,936 shares of the insurance provider's stock after buying an additional 19,613 shares during the period. Humana makes up 1.1% of Hotchkis & Wiley Capital Management LLC's portfolio, making the stock its 28th largest position. Hotchkis & Wiley Capital Management LLC owned approximately 1.02% of Humana worth $327,293,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. Vanguard Group Inc. lifted its position in Humana by 8.9% in the 1st quarter. Vanguard Group Inc. now owns 13,972,872 shares of the insurance provider's stock valued at $3,697,222,000 after acquiring an additional 1,143,662 shares in the last quarter. Pzena Investment Management LLC grew its stake in Humana by 6.1% in the 1st quarter. Pzena Investment Management LLC now owns 3,828,923 shares of the insurance provider's stock valued at $1,013,133,000 after buying an additional 219,541 shares during the last quarter. Davis Selected Advisers grew its stake in Humana by 3.3% in the 1st quarter. Davis Selected Advisers now owns 2,331,343 shares of the insurance provider's stock valued at $616,873,000 after buying an additional 74,434 shares during the last quarter. Northern Trust Corp grew its stake in Humana by 14.5% in the 4th quarter. Northern Trust Corp now owns 1,216,195 shares of the insurance provider's stock valued at $308,561,000 after buying an additional 153,739 shares during the last quarter. Finally, Dimensional Fund Advisors LP grew its stake in Humana by 4.3% in the 1st quarter. Dimensional Fund Advisors LP now owns 1,105,364 shares of the insurance provider's stock valued at $292,474,000 after buying an additional 45,627 shares during the last quarter. Institutional investors and hedge funds own 92.38% of the company's stock.

Humana Price Performance

NYSE:HUM traded down $1.57 on Wednesday, hitting $297.30. The company had a trading volume of 859,252 shares, compared to its average volume of 1,712,624. The stock has a market capitalization of $35.76 billion, a price-to-earnings ratio of 22.82, a PEG ratio of 1.75 and a beta of 0.44. The company has a current ratio of 1.95, a quick ratio of 1.95 and a debt-to-equity ratio of 0.69. The firm has a 50 day moving average of $250.98 and a two-hundred day moving average of $253.78. Humana Inc. has a 52 week low of $206.87 and a 52 week high of $382.72.

Humana (NYSE:HUM - Get Free Report) last released its quarterly earnings results on Wednesday, July 30th. The insurance provider reported $6.27 earnings per share (EPS) for the quarter, missing the consensus estimate of $6.32 by ($0.05). Humana had a net margin of 1.28% and a return on equity of 13.67%. The business had revenue of $32.39 billion for the quarter, compared to the consensus estimate of $31.85 billion. During the same period in the previous year, the business posted $6.96 EPS. Humana's revenue was up 9.6% on a year-over-year basis. Humana has set its FY 2025 guidance at 17.000- EPS. On average, research analysts anticipate that Humana Inc. will post 16.47 earnings per share for the current year.

Humana Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Friday, September 26th will be given a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.2%. The ex-dividend date of this dividend is Friday, September 26th. Humana's dividend payout ratio (DPR) is presently 27.17%.

Analysts Set New Price Targets

A number of research analysts have issued reports on the stock. Oppenheimer increased their target price on shares of Humana from $300.00 to $310.00 and gave the stock an "outperform" rating in a research report on Thursday, May 1st. Robert W. Baird decreased their target price on shares of Humana from $300.00 to $297.00 and set a "neutral" rating on the stock in a research report on Friday, July 25th. Truist Financial decreased their target price on shares of Humana from $280.00 to $260.00 and set a "hold" rating on the stock in a research report on Wednesday, July 16th. Barclays set a $275.00 target price on shares of Humana and gave the stock an "equal weight" rating in a research report on Thursday, July 31st. Finally, Wall Street Zen lowered shares of Humana from a "buy" rating to a "hold" rating in a research report on Saturday, August 2nd. Seven investment analysts have rated the stock with a Buy rating and sixteen have assigned a Hold rating to the company's stock. According to data from MarketBeat, the company presently has an average rating of "Hold" and an average price target of $283.29.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.